Biomaterial Database

[Nephrotic syndrome during long-term lithium therapy]. 1983

V M Ermolenko, and A Iu Nikolaev, and V A Varshavskiĭ, and M A Pal'tsev

UI	MeSH Term	Description	Entries
D008094	Lithium	An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER.	Lithium-7,Lithium 7
D009404	Nephrotic Syndrome	A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.	Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D016651	Lithium Carbonate	A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.	CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

V M Ermolenko, and A Iu Nikolaev, and V A Varshavskiĭ, and M A Pal'tsev

Nephrotic syndrome during lithium therapy.

December 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

V M Ermolenko, and A Iu Nikolaev, and V A Varshavskiĭ, and M A Pal'tsev

[Nephrotic syndrome and lithium therapy].

May 2001, Medicina clinica,

V M Ermolenko, and A Iu Nikolaev, and V A Varshavskiĭ, and M A Pal'tsev

[Nephrotic syndrome under lithium therapy].

January 1990, Presse medicale (Paris, France : 1983),

V M Ermolenko, and A Iu Nikolaev, and V A Varshavskiĭ, and M A Pal'tsev

Nephrotic syndrome associated with lithium therapy.

September 1997, The American journal of psychiatry,

V M Ermolenko, and A Iu Nikolaev, and V A Varshavskiĭ, and M A Pal'tsev

Nephrotic syndrome secondary to lithium therapy.

January 1982, Nephron,